000877956 001__ 877956
000877956 005__ 20220930130245.0
000877956 0247_ $$2doi$$a10.3389/fnins.2020.00594
000877956 0247_ $$2Handle$$a2128/27325
000877956 0247_ $$2altmetric$$aaltmetric:86163368
000877956 0247_ $$2pmid$$a32848528
000877956 0247_ $$2WOS$$aWOS:000558856700001
000877956 037__ $$aFZJ-2020-02535
000877956 082__ $$a610
000877956 1001_ $$0P:(DE-Juel1)173070$$aKohl, Simon H.$$b0$$eCorresponding author
000877956 245__ $$aThe Potential of Functional Near-Infrared Spectroscopy-Based Neurofeedback—A Systematic Review and Recommendations for Best Practice
000877956 260__ $$aLausanne$$bFrontiers Research Foundation$$c2020
000877956 3367_ $$2DRIVER$$aarticle
000877956 3367_ $$2DataCite$$aOutput Types/Journal article
000877956 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1615280047_28361
000877956 3367_ $$2BibTeX$$aARTICLE
000877956 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000877956 3367_ $$00$$2EndNote$$aJournal Article
000877956 520__ $$aBackground: The effects of electroencephalography (EEG) and functional magnetic resonance imaging (fMRI)-neurofeedback on brain activation and behaviors have been studied extensively in the past. More recently, researchers have begun to investigate the effects of functional near-infrared spectroscopy-based neurofeedback (fNIRS-neurofeedback). FNIRS is a functional neuroimaging technique based on brain hemodynamics, which is easy to use, portable, inexpensive, and has reduced sensitivity to movement artifacts.Method: We provide the first systematic review and database of fNIRS-neurofeedback studies, synthesizing findings from 22 peer-reviewed studies (including a total of N=441 participants; 337 healthy, 104 patients). We (1) give a comprehensive overview of how fNIRS-neurofeedback training protocols were implemented, (2) review the online signal-processing methods used, (3) evaluate the quality of studies using pre-set methodological and reporting quality criteria and also present statistical sensitivity/power analyses, (4) investigate the effectiveness of fNIRS-neurofeedback in modulating brain activation, and (5) review its effectiveness in changing behavior in healthy and pathological populations.Results and discussion: (1-2) Published studies are heterogeneous (e.g., neurofeedback targets, investigated populations, applied training protocols, and methods). (3) Large randomized controlled trials are still lacking. In view of the novelty of the field, the quality of the published studies is moderate. We identified room for improvement in reporting important information and statistical power to detect realistic effects. (4) Several studies show that people can regulate hemodynamic signals from cortical brain regions with fNIRS-neurofeedback and (5) these studies indicate the feasibility of modulating motor control and prefrontal brain functioning in healthy participants and ameliorating symptoms in clinical populations (stroke, ADHD, autism, and social anxiety). However, valid conclusions about specificity or potential clinical utility are premature.Conclusion: Due to the advantages of practicability and relatively low cost, fNIRS-neurofeedback might provide a suitable and powerful alternative to EEG and fMRI neurofeedback and has great potential for clinical translation of neurofeedback. Together with more rigorous research and reporting practices, further methodological improvements may lead to a more solid understanding of fNIRS-neurofeedback. Future research will benefit from exploiting the advantages of fNIRS, which offers unique opportunities for neurofeedback research.
000877956 536__ $$0G:(DE-HGF)POF3-899$$a899 - ohne Topic (POF3-899)$$cPOF3-899$$fPOF III$$x0
000877956 588__ $$aDataset connected to CrossRef
000877956 7001_ $$0P:(DE-HGF)0$$aMehler, David M. A.$$b1
000877956 7001_ $$0P:(DE-HGF)0$$aLührs, Michael$$b2
000877956 7001_ $$0P:(DE-HGF)0$$aThibault, Robert T.$$b3
000877956 7001_ $$0P:(DE-Juel1)174172$$aKonrad, Kerstin$$b4
000877956 7001_ $$0P:(DE-HGF)0$$aSorger, Bettina$$b5
000877956 773__ $$0PERI:(DE-600)2411902-7$$a10.3389/fnins.2020.00594$$gVol. 14, p. 594$$p594$$tFrontiers in neuroscience$$v14$$x1662-453X$$y2020
000877956 8564_ $$uhttps://juser.fz-juelich.de/record/877956/files/fnins-14-00594.pdf$$yOpenAccess
000877956 8564_ $$uhttps://juser.fz-juelich.de/record/877956/files/fnins-14-00594.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000877956 8767_ $$d2020-07-14$$eAPC$$jDeposit$$lDeposit: Frontiers$$zUSD 2507.50, Reporting 202005
000877956 909CO $$ooai:juser.fz-juelich.de:877956$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000877956 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)173070$$aForschungszentrum Jülich$$b0$$kFZJ
000877956 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)174172$$aForschungszentrum Jülich$$b4$$kFZJ
000877956 9131_ $$0G:(DE-HGF)POF3-899$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000877956 9132_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000877956 9141_ $$y2020
000877956 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-01-09
000877956 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000877956 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT NEUROSCI-SWITZ : 2018$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000877956 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$f2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-01-09
000877956 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-09
000877956 9201_ $$0I:(DE-Juel1)INM-11-20170113$$kINM-11$$lJara-Institut Quantum Information$$x0
000877956 980__ $$ajournal
000877956 980__ $$aVDB
000877956 980__ $$aUNRESTRICTED
000877956 980__ $$aI:(DE-Juel1)INM-11-20170113
000877956 980__ $$aAPC
000877956 9801_ $$aAPC
000877956 9801_ $$aFullTexts